PACTR202008475715326
Completed
未知
EFFECTS OF ANTENATAL ANTIHELMINTHIC TREATMENT ON PREGNANCY OUTCOMES IN UITH ILORIN: A RANDOMISED CONTROLLED TRIAL.
Dr Afusat Olabinjo0 sites176 target enrollmentJuly 21, 2020
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Helminthiasis
- Sponsor
- Dr Afusat Olabinjo
- Enrollment
- 176
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •All consenting pregnant women with singleton foetus presenting between 14 and 26 weeks.
Exclusion Criteria
- •Non consenting pregnant women.
- •Patients with known hypersensitivity to benzimidazole.
- •Baseline haemoglobin concentration less than 7g/dl.
- •Patients with multiple gestations.
- •Patients with sickle cell disease
- •Patients with chronic kidney disease.
- •Retroviral disease patients.
- •Patients that may require blood transfusion during the course of pregnancy.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Unknown
Not Applicable
HelmvaccPACTR201303000434188Dr. Ayola Akim Adegnika, MD, PhD312
Recruiting
Phase 4
The effect of antenatal acetaminophen administration on breathing effort of premature infants at birth: a pilot studyNL-OMON53465eids Universitair Medisch Centrum40
Active, not recruiting
Phase 1
The effect of paracetamol on breathing of premature infants at birthEUCTR2022-003415-29-NLeiden University Medical Centre40
Completed
Not Applicable
A case-control study on perinatal outcomes of hypertension in pregnancy.Health Condition 1: O100- Pre-existing essential hypertension complicating pregnancy, childbirth and the puerperiumCTRI/2018/12/016694Binita Sharma140
Active, not recruiting
Not Applicable
APPA Neonatal and Paediatric Penicillins StudyThe study is not restricted to any specific condition. The study population will include children (aged under 16 years) admitted to hospital and routinely prescribed one of the study penicillins according to local hospital policy for any indication (including medical or surgical prophylaxis).Therapeutic area: Diseases [C] - Bacterial Infections and Mycoses [C01]EUCTR2013-002366-40-GBSt George’s, University of London